Germany’s Bayer to double investments in Egypt in five years

INVESTMENT WATCH- German pharma player Bayer plans to double its investment in Egypt in the next five years to EUR 140 mn by introducing new cardiac, oncological and women’s health products, Bayer Managing Director for Egypt Hatem Safei told Al Mal. Safei claims that at 54%, Bayer’s top line in Egypt grew the fastest in the Egyptian industry this year.